Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Kuros Biosciences News

    6,81 CHF -1,16% -0,08 CHF
    In : 6,9636 € | 26.04.24 17:19:55 SIX Swiss Exchange aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A2ALS5
    ISIN: CH0325814116
    US-Symbol: CSBTF
    Typ: Aktie

    Kuros Biosciences News

    24.04.24 - DGAP
    Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales
    Kuros Biosciences AG / Key word(s): Quarter Results/Regulatory Approval Kuros reports Corporate Highlights as of Q1 2024 including increase in direct MagnetOsTM sales 24-Apr-...
    17.04.24 - DGAP
    Annual General Meeting of Kuros Biosciences approves all resolutions
    Kuros Biosciences AG / Key word(s): AGMEGM Annual General Meeting of Kuros Biosciences approves all resolutions 17.04.2024 / 14:05 CET/CEST
    13.03.24 - DGAP
    Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023
    Kuros Biosciences AG / Key word(s): Annual Results Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023 13-...
    08.03.24 - DGAP
    Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update
    Kuros Biosciences AG / Key word(s): Annual Results Kuros Biosciences to Report Full Year Financial Results for 2023 and Provide Corporate Update 08.03.2024 / 07:00 CET/CEST
    01.02.24 - DGAP
    Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference
    Kuros Biosciences AG / Key word(s): Conference Kuros Biosciences to Present at the CG 2024 Musculoskeletal Conference 01.02.2024 / 07:00 CET/CEST
    31.01.24 - DGAP
    Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and Regulatory Clearance of MagnetOs Granules and MagnetOs Putty in New Zealand
    Kuros Biosciences AG / Key word(s): Regulatory Admission/Market Launch Kuros Biosciences Receives US FDA 510K Clearance for MagnetOs Granules for Interbody Use and ...
    08.01.24 - Wikifolio
    Die heißesten Aktien der letzten Woche
    Hier erfährst du, welche Aktien letzte Woche besonders oft ge- oder verkauft wurden und welche Motive dafür entscheidend waren.
    04.01.24 - DGAP
    Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA
    Kuros Biosciences AG / Key word(s): Study results/Preliminary Results Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including ...
    27.12.23 - DGAP
    Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA
    Kuros Biosciences AG / Key word(s): Study/Study results Kuros Biosciences Announces Results from Two Prospective Randomized Clinical Trials: STRUCTURE and MAXA 27-Dec-...
    28.11.23 - DGAP
    Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages
    Kuros Biosciences AG / Key word(s): Regulatory Approval Kuros Biosciences Receives FDA Clearance for Use of MagnetOs in Interbody Spinal Cages 28.11.2023 / 18:00 CET/CEST
    12.10.23 - DGAP
    Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the Executive Management
    Kuros Biosciences AG / Key word(s): Quarter Results Kuros reports a 150% increase in direct MagnetOs sales in the first nine months of 2023 and announces changes within the ...
    09.08.23 - DGAP
    Kuros Biosciences Reports Results for First Half 2023
    Kuros Biosciences AG / Key word(s): Half Year Results Kuros Biosciences Reports Results for First Half 2023 09-Aug-2023 / 07:00 CET/CEST Release of an ad hoc announcement ...
    13.07.23 - DGAP
    Kuros Biosciences Announces Completion of Enrollment in the Fibrin-PTH Phase 2 Trial
    Kuros Biosciences AG / Key word(s): Study results Kuros Biosciences Announces Completion of Enrollment in the Fibrin-​PTH Phase 2 Trial 13.07.2023 / 19:29 CET/CEST
    08.05.23 - DGAP
    Annual General Meeting of Kuros Biosciences approves all resolutions
    Kuros Biosciences AG / Key word(s): Miscellaneous Annual General Meeting of Kuros Biosciences approves all resolutions 08-May-2023 / 17:18 CET/CEST Release of an ad hoc ...
    27.04.23 - DGAP
    Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023
    Kuros Biosciences AG / Key word(s): Miscellaneous Kuros reports 168% increase in direct MagnetOs sales in the first quarter of 2023 27-Apr-2023 / 07:00 CET/CEST Release of an ...
    15.03.23 - DGAP
    Kuros Biosciences reports results for the full year 2022
    Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences reports results for the full year 2022 15-March-2023 / 07:00 CET/CEST Release of an ad hoc announcement ...
    21.02.23 - DGAP
    Kuros Biosciences Announces Publication of Supportive Osteoimmunology Data for MagnetOs Bone Graft
    Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences Announces Publication of Supportive Osteoimmunology Data for MagnetOs Bone Graft 21.02.2023 / 07:00 ...
    16.02.23 - DGAP
    Kuros Biosciences Announces Changes to Executive Management Team
    Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences Announces Changes to Executive Management Team 16-Feb-2023 / 18:01 CET/CEST Release of an ad hoc ...
    23.11.22 - DGAP
    Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH
    Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-​PTH 23.11.2022 / 07:00 CET/CEST
    02.11.22 - DGAP
    Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules
    Kuros Biosciences AG / Key word(s): Study Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules 02.11.2022 / 07:00 CET/CEST

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »